NCT00740779 - Use of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome. | Biotech Hunter

Enrollment

153

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Interventions

DRUG

Silodosin 8 mg

Silodosin 8 mg daily

DRUG

Placebo

DRUG

Silodosin 4 mg

Silodosin 4 mg daily

Trial Locations (22)

Watson Investigational Site, San Diego

Watson Investigational Site, Denver

Watson Investigational Site, Columbus

Watson Investigational Site, Roswell

Watson Investigational Site, Jeffersonville

Watson Investigational Site, West Des Moines

Watson Investigational Site, Baltimore

Watson Investigational Site, Boston

Watson Investigational Site, Watertown

Watson Investigational Site, Omaha

Watson Investigational Site, Voorhees Township

Watson Investigational Site, Albuquerque

Watson Investigational Site, Garden City

Watson Investigational Site, Kingston

Watson Investigational Site, New York

Watson Investigational Site, Poughkeepsie

Watson Investigational Site, Columbus

Watson Investigational Site, Bethany

Watson Investigational Site, Edmond

Watson Investigational Site, State College

Watson Investigational Site, Mountlake Terrace

Watson Investigational Site, Spokane